Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah R Kaye

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
BJU International|June 11, 2023
Drug costs: acquisition costs are critical but not the entire story of financial toxicityDeborah R Kaye
Surgical Oncology Clinics of North America|November 15, 2021
The Impact of Health Delivery Integration on Cancer OutcomesVishnukamal Golla, Deborah R Kaye
JU Open Plus|May 12, 2025
Reply to Editorial Comment: Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative StudyJeremy Kurnot, Deborah R Kaye
The New England Journal of Medicine|November 8, 2013
Grading a physician's value--the misapplication of performance measurementRobert A Berenson, Deborah R Kaye
Current Opinion in Urology|September 2, 2024
Reducing financial toxicity in bladder cancer careJeremy A Kurnot, Deborah R Kaye
Current Opinion in Urology|November 22, 2013
Robotic ultrasound and needle guidance for prostate cancer management: review of the contemporary literatureDeborah R Kaye, Dan Stoianovici, Misop Han
Current Opinion in Urology|April 26, 2017
Alternative payment models and urologyDeborah R Kaye, David C Miller, Chad Ellimoottil
Current Urology Reports|December 13, 2022
Should Transperineal Prostate Biopsy Be the Standard of Care?Rand N Wilcox Vanden Berg, Arvin K George, Deborah R Kaye
Nature Reviews. Urology|December 24, 2014
Robotic surgery in urological oncology: patient care or market share?Deborah R Kaye, Jeffrey K Mullins, H Ballentine Carter, et al.
Urology|June 8, 2012
A 66-year-old man with prostate-specific antigen recurrence and lung mass after radical prostatectomyDeborah R Kaye, Patrick C Walsh, George J Netto, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
BJU International|June 11, 2023
Drug costs: acquisition costs are critical but not the entire story of financial toxicityDeborah R Kaye
Surgical Oncology Clinics of North America|November 15, 2021
The Impact of Health Delivery Integration on Cancer OutcomesVishnukamal Golla, Deborah R Kaye
JU Open Plus|May 12, 2025
Reply to Editorial Comment: Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative StudyJeremy Kurnot, Deborah R Kaye
The New England Journal of Medicine|November 8, 2013
Grading a physician's value--the misapplication of performance measurementRobert A Berenson, Deborah R Kaye
Current Opinion in Urology|September 2, 2024
Reducing financial toxicity in bladder cancer careJeremy A Kurnot, Deborah R Kaye
Current Opinion in Urology|November 22, 2013
Robotic ultrasound and needle guidance for prostate cancer management: review of the contemporary literatureDeborah R Kaye, Dan Stoianovici, Misop Han
Current Opinion in Urology|April 26, 2017
Alternative payment models and urologyDeborah R Kaye, David C Miller, Chad Ellimoottil
Current Urology Reports|December 13, 2022
Should Transperineal Prostate Biopsy Be the Standard of Care?Rand N Wilcox Vanden Berg, Arvin K George, Deborah R Kaye
Nature Reviews. Urology|December 24, 2014
Robotic surgery in urological oncology: patient care or market share?Deborah R Kaye, Jeffrey K Mullins, H Ballentine Carter, et al.
Urology|June 8, 2012
A 66-year-old man with prostate-specific antigen recurrence and lung mass after radical prostatectomyDeborah R Kaye, Patrick C Walsh, George J Netto, et al.
Pageof 6